CLOV vs MSFT: Which Stock is Better?
Side-by-side comparison of Clover Health Investments Corp and Microsoft Corporation in 2026
CLOV
Clover Health Investments Corp
$4.16
MSFT
Microsoft Corporation
$510.89
Key Metrics Comparison
| Metric | CLOV | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.55B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | CLOV |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 50.1% | 18.4% | CLOV |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze CLOV
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CLOV or MSFT a better investment?
Comparing CLOV and MSFT: Clover Health Investments Corp has a market cap of $1.55B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CLOV and MSFT?
CLOV (Clover Health Investments Corp) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CLOV or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CLOV or MSFT?
CLOV has higher revenue growth at 50.1% vs 18.4% for MSFT.
Which company is more profitable: CLOV or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for CLOV.
Which is the larger company: CLOV or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.55B for CLOV.
Should I buy CLOV or MSFT in 2026?
Both CLOV and MSFT have investment merit. CLOV trades at $4.16 while MSFT trades at $510.89. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CLOV and MSFT stock?
Key differences: Market Cap ($1.55B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (50.1% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy CLOV or MSFT in 2026?
The choice between CLOV and MSFT depends on your investment goals. CLOV shows higher revenue growth (50.1%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CLOV and MSFT?
CLOV (Clover Health Investments Corp) has a market cap of $1.55B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.